540729 Stock Overview
Vanta Bioscience Limited, together with its subsidiaries, operates as a preclinical contract research organization in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Vanta Bioscience Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹61.51 |
| 52 Week High | ₹101.64 |
| 52 Week Low | ₹37.00 |
| Beta | 0.79 |
| 1 Month Change | -13.18% |
| 3 Month Change | n/a |
| 1 Year Change | 17.72% |
| 3 Year Change | -62.54% |
| 5 Year Change | -68.46% |
| Change since IPO | 22.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540729 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -7.5% | 2.7% | 2.8% |
| 1Y | 17.7% | 17.9% | 46.6% |
Return vs Industry: 540729 matched the Indian Life Sciences industry which returned 18.5% over the past year.
Return vs Market: 540729 underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| 540729 volatility | |
|---|---|
| 540729 Average Weekly Movement | 11.7% |
| Life Sciences Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 540729's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 540729's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 47 | Dopesh Mulakala | www.vantabio.com |
Vanta Bioscience Limited, together with its subsidiaries, operates as a preclinical contract research organization in India. It provides toxicology evaluation services for clientele in pharmaceutical, biotech, medical device, cosmetics, agri-foods, food supplements, feed additives, and chemical industries. The company offers range of services in method development, validation, impurity profiling, impurity isolation, characterization, certification and evaluation, mammalian and genetic toxicology, drug metabolism, pharmacokinetics, and bio-analysis during the preclinical stage of drug development.
Vanta Bioscience Limited Fundamentals Summary
| 540729 fundamental statistics | |
|---|---|
| Market cap | ₹388.25m |
| Earnings (TTM) | -₹44.57m |
| Revenue (TTM) | ₹102.66m |
3.8x
P/S Ratio-8.7x
P/E RatioIs 540729 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540729 income statement (TTM) | |
|---|---|
| Revenue | ₹102.66m |
| Cost of Revenue | ₹13.61m |
| Gross Profit | ₹89.05m |
| Other Expenses | ₹133.62m |
| Earnings | -₹44.57m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.06 |
| Gross Margin | 86.75% |
| Net Profit Margin | -43.41% |
| Debt/Equity Ratio | 295.9% |
How did 540729 perform over the long term?
See historical performance and comparison